Complement-Mediated Bone Healing Dynamics

The complement cascade, traditionally appreciated for its role in innate immunity, has emerged as a pivotal regulator of bone repair. Activation of complement components generates anaphylatoxins such as C5a that orchestrate the early inflammatory milieu at fracture sites. Through binding to its receptors on immune and bone cells, C5a modulates recruitment of neutrophils and macrophages, fine-tunes osteoclastogenesis and influences osteoblast function. A balanced complement response promotes timely cartilage-to-bone transformation within the fracture callus, supports neovascularisation and guides remodelling, whereas dysregulated complement activation can impair ossification and reduce mechanical integrity. Understanding these dynamics has revealed novel entry points for therapeutic intervention in trauma-induced non-union, osteoporosis and inflammatory bone loss, underscoring the dual nature of complement as both friend and foe in skeletal regeneration.

Research from Nature Portfolio

Recent studies have dissected the distinct contributions of the two C5a receptors in bone turnover and healing. In models lacking C5aR1 or C5aR2, basal bone mass was elevated due to reduced osteoclast formation or increased osteoblast numbers, respectively, yet both showed impaired fracture healing. Deletion of C5aR1 attenuated the early inflammatory surge at the injury site, while absence of C5aR2 paradoxically amplified local inflammation. In both knockouts, cartilage-to-bone conversion was delayed, callus remodelling was disrupted and mechanical strength was compromised. These findings demonstrate that C5aR1 and C5aR2 act in concert to regulate the immune response and ensure effective endochondral ossification during bone repair.

Research from all publishers

Work in human cells has shown that complement-mediated signals are integrated into the transcriptional landscape of osteoclast precursors. High-throughput sequencing during in vitro differentiation revealed temporal gene-expression patterns linked to postmenopausal osteoporosis risk. Pharmacological activation or inhibition of the C5a receptor altered osteoclast numbers and resorptive activity, highlighting C5aR1 as a druggable target to rebalance bone remodelling.

In a murine model of postmenopausal osteoporosis, selective deletion of C5aR1 in osteoblasts prevented ovariectomy-induced bone loss by reducing RANKL secretion and thus osteoclast activation. This cell-type-specific approach underlines the potential for complement-directed therapies that spare systemic immunity while preserving bone integrity.

Foundational work in complement-deficient mice demonstrated that absence of C3 or C5 impairs early callus formation, reduces new bone deposition and weakens fracture healing. Notably, terminal complement activation was essential for full mechanical recovery, suggesting that a threshold of complement activity is required to drive tissue regeneration and avoid non-union.

Complement-Mediated Bone Healing Dynamics publication trend

The graph below shows the total number of articles in complement-mediated bone healing dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Complement system: A proteolytic cascade in innate immunity that produces effectors (C3a, C5a) to clear pathogens and modulate inflammation.

Anaphylatoxin: Small complement-derived peptide (eg C5a) that acts as a potent chemoattractant and inflammatory mediator.

C5aR1 and C5aR2: G-protein-coupled receptors for C5a, expressed on immune cells, osteoclasts and osteoblasts, mediating distinct signalling pathways.

Osteoclastogenesis: Differentiation of monocyte-macrophage precursors into bone-resorbing osteoclasts.

Osteoblast: Bone-forming cell responsible for matrix deposition and mineralisation.

Cartilage-to-bone transformation: Endochondral ossification process by which a cartilage template is replaced by bone during fracture repair.

RANKL: Receptor activator of nuclear factor κB ligand; a key osteoblast-derived cytokine that drives osteoclast differentiation and activity.

References

1. Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity. Bone Research (2024).
2. Complement receptors C5aR1 and C5aR2 act differentially during the early immune response after bone fracture but are similarly involved in bone repair. Scientific Reports (2017).
3. Complement C3 and C5 Deficiency Affects Fracture Healing. PLOS ONE (2013).
4. Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis. Frontiers in Endocrinology (2022).